#VisualAbstract: Adjuvant nivolumab may be promising for treatment of completely resected Merkel cell carcinoma
1. Disease-free survival at 24 months was 84% in the nivolumab group compared to 73% in the observation group. 2. ...
Tag: Merkel Cell Carcinoma
Adjuvant nivolumab may be promising for treatment of completely resected Merkel cell carcinoma
1. Disease-free survival at 24 months was 84% in the nivolumab group compared to 73% in the observation group. 2. ...
Stereotactic body radiation does not improve outcomes in patients with advanced Merkel cell carcinoma receiving nivolumab and ipilimumab
1. Objective response rate was not significantly different in patients treated with stereotactic body radiotherapy compared to those without. 2. ...
#VisualAbstract: Solid organ transplant recipients are at an increased risk of developing non-melanoma skin cancers
Click to read this study in JAMA Dermatology.
#VisualAbstract: Differences in Merkel cell carcinoma recurrence and survival rates stratified by cancer stage
Click to read this study in JAMA Dermatology.
#VisualAbstract: Tumor primary site may be a prognostic factor for patients with Merkel cell carcinoma
Click to read the study in the Journal of the American Academy of Dermatology.
#VisualAbstract: Local excision margins greater than 1 cm and receipt of radiotherapy are associated with improved overall survival in Merkel cell carcinoma
Click to read the study in JAMA Dermatology.
#VisualAbstract: Higher metastatic lymph node burden is associated with worse overall survival in Merkel cell carcinoma
Click to read the study in the Journal of the American Academy of Dermatology.
